NewSquare Capital’s Medpace MEDP Stock Holding History

NewSquare Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7	Closed	-$2.2K	–	799
2025 Q2	$2.2K	Sell	7 -5	-42%	-$1.5K	﹤0.01%	948
2025 Q1	$3.66K	Buy	+12	New	+$4.04K	﹤0.01%	746

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NewSquare Capital's MEDP Position: Q3 2025 in Review

NewSquare Capital sold out of Medpace (MEDP) in Q3 2025, closing a stake of 7 shares — an estimated $2.2K sold.

NewSquare Capital first reported a position in MEDP in Q1 2025 and held it in 2 quarters. The position peaked at $3.66K in Q1 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

NewSquare Capital reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 7 Medpace shares in Q3 2025, an estimated $2.2K.
NewSquare Capital first reported a position in Medpace in Q1 2025 and held it in 2 quarters.
NewSquare Capital's Medpace position peaked at $3.66K in Q1 2025.
672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.